Intracerebral Hemorrhage research hub
8 indexed studies · 6 currently recruiting
- recruitingPHASE3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
This study is testing a new treatment called rFVIIa for a serious type of stroke caused by bleeding in the brain. It aims to see if giving this medicine quickly can improve recovery and reduce further bleeding for certain patients.
United States · Canada · Germany - recruiting
Augmented Renal Clearance in Neurocritical Care
This study looks at how certain serious brain conditions might cause kidneys to work extra fast, which can make medicines less effective. Researchers want to understand this better to help doctors give the right amount of medicine, improving care for patients.
United States · Canada - not yet recruiting
High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers
This study is looking at people who've had a brain bleed to see if certain signs on their brain scans can help predict their risk of death or long-term problems. It aims to improve how we identify patients who might need extra care.
France - recruiting
Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)
This study aims to improve care for people in the UK who have a type of stroke called an intracerebral haemorrhage (ICH). Researchers want to see if a special treatment plan can reduce deaths and disabilities after this serious condition.
France - recruitingPHASE4
International Care Bundle Evaluation in Cerebral Hemorrhage Research
This study, called I-CATCHER, is looking into whether a special care package helps people who have a stroke caused by bleeding in the brain (intracerebral haemorrhage). It aims to improve recovery for these patients by testing a new approach to treatment.
United States · Australia · Canada - recruitingPHASE3
Avoiding Anticoagulation After IntraCerebral Haemorrhage
This study looks at the best way for people with a history of bleeding in the brain and an irregular heartbeat (atrial fibrillation) to prevent future strokes. It compares an anti-clotting drug (Apixaban), a heart procedure (left atrial appendage closure), and usual care.
France - active not recruitingPHASE3
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
This study is testing a new treatment for a type of stroke called 'intracerebral haemorrhage' (bleeding in the brain). Doctors want to see if giving a drug called rFVIIa soon after the stroke can reduce bleeding and improve recovery.
United States · Canada · Germany - authorisedTherapeutic exploratory (Phase II)
Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. The INFINITE Study
This study, called INFINITE, looks at how brain inflammation and blood vessel damage might affect recovery after a brain bleed (intracerebral hemorrhage). Researchers use special scans to see these changes and how they link to a person's recovery six months later.
France